~~<i id='48B40EBC67'><strike id='48B40EBC67'><tt id='48B40EBC67'><pre id='48B40EBC67'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：hotspot 2025-09-28 07:28:37 Page View：7

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.
Next article： Medical records are filled with copy

explore

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Pharma needs to include young adults in clinical research

AdobeThepharmaceuticalindustryhasrapidlyadaptedtopromotingprescriptiondrugstoyoungpeopleonTikTok,Ins

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

White House touts steps to stem shortages of cancer treatments

TheWhiteHouseoutlineditseffortstoendshortagesofthreekeygenericchemotherapies.Butexpertswantmoremored